Where is my NIH Notice of Award?

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

Oh the NIH grant applications with October Council reviews! They lead to such consternation among applicants.

Remember that at the first level review (the study section), reviewers award a score, not money. The second level review (at Council) is where award decisions are made — and contrary to popular belief, the decision is not based entirely on the score. Unfortunately, if your application is discussed at an October Advisory Council for your institute, your funding decision is being made just as NIH is awaiting its funding bill from Congress. For those who do not know, federal agencies have an October 1 fiscal calendar. However, Congress rarely has funding bills approved by October 1 — except in presidential election years, when Congress sometimes approves a bill quickly to demonstrate to voters that they can ‘play nicely’ with their colleagues. For most years, on October 1 there is no funding bill and federal agencies operate on a Continuing Resolution, which is a temporary spending bill. With a CR in place, most ICs will operate at 80% of their previous year’s budget, to be on the safe side, until they get a firm budget number for the new year.

NIH is currently operating under a Continuing Resolution, meaning that they do not yet have a funding bill from Congress and do not have a firm budget number for FY23. That can delay funding decisions. It looks like there is already a draft bill from the Appropriations Subcommittee, with some comfortable increases yet again for NIH. But Congress has not yet approved the entire funding bill for Health and Human Services.

What does that mean? It means that if your application was reviewed at October Council, your funding decision is likely to be delayed. There isn’t much you can do but sit tight and await the funding bill, after which the ICs will finalize their FY23 budgets, after which (hopefully) you will receive your NOA.

Dr. Meg Bouvier

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She's recently worked with more than 40% of the nation's highest-performing hospitals*, four of the top 10 cancer hospitals, three of the top five medical schools for research, and 14 NCI-designated cancer centers. Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*Our clients include 9 of the top 22 hospitals as recognized by the 2023/24 US News & World Report honor roll

Categories:
Related posts

You May Also Be Interested In

Bouvier Grant Group logo white
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH October 2023 Newsletter cover